-
公开(公告)号：KR100815259B1
公开(公告)日：2008-03-19
申请号：KR1020060129340
申请日：2006-12-18
IPC: A23D7/04
CPC classification number: A23D7/04
Abstract: A method of manufacturing microencapsulated oil powder using herbal extract and an emulsification buffer agent having antioxidant effect to inhibit oil oxidation and an excipient such as dextrin to coat oil powder is provided to maximally inhibit the formation of oxidation products such as peroxides, aldehydes and ketones. Microencapsulated oil powder having long-lasting freshness is prepared by the step of: mixing 6.3 to 7.3% by weight of milk protein, 22.6 to 23.7% by weight of edible oil and fat, 0.3 to 0.9% by weight of an emulsifier and 68.1 to 70.8% by weight of purified water; adding a mixture of herbal extract and emulsification buffer agent in a weight ratio of 1:0.3 to 0.5 thereto; adding dextrin thereto in a weight ratio of 1:0.3 to 0.5; sterilizing the mixture at 75 to 85deg.C for 20 to 40min; homogenizing the mixture at 3,000 to 3,800rpm for 20 to 40min; filtering with a magnetic container having a filter net of 20 to 60 meshes and a magnetic rod with 8,000 to 12,000 Gauss; and drying with a spray drier. The herbal extract is any one of rosemary extract, broccoli extract and citrus extract. The emulsification buffer agent is monobasic phosphate monobasic, dibasic sodium phosphate, tribasic sodium phosphate, sodium pyrophosphate, monobasic potassium phosphate, dibasic potassium phosphate and tribasic potassium phosphate.
Abstract translation: 提供使用草药提取物制备微胶囊化油粉的方法和具有抑制油氧化的抗氧化作用的乳化缓冲剂和赋予涂料油糊的糊精等赋形剂以最大限度地抑制氧化产物如过氧化物，醛和酮的形成。 通过以下步骤制备具有持久新鲜度的微胶囊化油粉：将6.3至7.3重量％的乳蛋白，22.6至23.7重量％的食用油和脂肪，0.3至0.9重量％的乳化剂和68.1至 70.8重量％的净化水; 以1:0.3至0.5的重量比加入草药提取物和乳化缓冲剂的混合物; 以1:0.3至0.5的重量比加入糊精; 将混合物在75〜85℃下灭菌20〜40分钟; 将混合物在3,000至3800rpm下匀化20至40分钟; 用具有20至60目筛网的磁性容器和8,000至12,000高斯的磁棒过滤; 并用喷雾干燥器干燥。 草药提取物是迷迭香提取物，西兰花提取物和柑橘提取物中的任何一种。 乳化缓冲剂是磷酸二氢钙，磷酸氢二钠，磷酸三钠，焦磷酸钠，磷酸氢二钾，磷酸氢二钾，磷酸三钾等。
-
公开(公告)号：KR101912814B1
公开(公告)日：2018-10-29
申请号：KR1020180103629
申请日：2018-08-31
Abstract: 본발명은쌀겨추출물분말의제조방법에관한것으로, 쌀겨추출물의산패를효과적으로억제하고, 상기쌀겨추출물을분무건조했을때 생산수율및 분말의흐름성을현저히향상시킬수 있는쌀겨추출물분말의제조방법을제공하는것이다. 본발명에따른쌀겨추출물분말의제조방법은쌀겨추출물의산패를억제하여쌀겨의유효성분을효과적으로보호하고, 상기쌀겨추출물을분무건조할때 생산수율및 분말의흐름성(유동성)을향상시킬수 있어가공성이뛰어난효과를나타낸다.
-
公开(公告)号：KR1020180100102A
公开(公告)日：2018-09-07
申请号：KR1020180103629
申请日：2018-08-31
CPC classification number: A23L7/198 , A23L29/03 , A23P10/47 , A23V2002/00 , A23V2200/02
Abstract: 본발명은쌀겨추출물분말의제조방법에관한것으로, 쌀겨추출물의산패를효과적으로억제하고, 상기쌀겨추출물을분무건조했을때 생산수율및 분말의흐름성을현저히향상시킬수 있는쌀겨추출물분말의제조방법을제공하는것이다. 본발명에따른쌀겨추출물분말의제조방법은쌀겨추출물의산패를억제하여쌀겨의유효성분을효과적으로보호하고, 상기쌀겨추출물을분무건조할때 생산수율및 분말의흐름성(유동성)을향상시킬수 있어가공성이뛰어난효과를나타낸다.
-
公开(公告)号：KR1020170135350A
公开(公告)日：2017-12-08
申请号：KR1020160067129
申请日：2016-05-31
Applicant: (주)에스.앤.디
CPC classification number: A23L27/88 , A23L7/104 , A23L7/107 , A23L27/10 , A23V2002/00 , A23V2250/21 , A23V2250/55
Abstract: 쌀겨발효물의효소분해물을포함하는염미증강소재및 이를이용하는저염조미료에관한것이다. 보다상세하게는쌀겨와물을 1 : 2~3의비율로혼합하고 95∼100℃, 1.5∼2.5시간동안증자하는단계와, 쌀겨증자물에바실러스균 13%(v/w) 를접종하여 36∼38℃에서 46∼50 시간동안발효시킨후, 열수를넣고추출한다음규조토로여과시켜쌀겨발효추출물을얻는단계와, 상기의쌀겨발효추출물에 protease0.05∼0.15%(v/w) 넣고, 40℃에서 4시간동안반응시켜쌀겨발효추출효소분해물-1을얻고, 그리고상기의쌀겨발효추출물에 pectinase 0.05∼0.15% (v/w) 넣고, 45℃에서 4시간동안반응시켜쌀겨발효추출효소분해물-2를얻는효소분해단계와, 각각의쌀겨발효추출효소분해물을 85℃, 15분간실활시키고 15 brix로농축시켜재차 85℃, 15분간살균및 배합하고분무건조기를이용하여분말화 (inlet 185 ± 5℃, outlet 95 ± 5℃)하는단계로구성되어쌀겨발효추출효소분해물-1와쌀겨발효추출효소분해물-2를얻는다.
Abstract translation: 发酵米糠的酶水解物和使用其的低盐调味料。 更具体地，米糠与水和一种以2:1的比率接种到3并且进一步包括：提供95〜100℃，1.5〜2.5小时后，芽孢杆菌属细菌和13％的增加在米糠与水（v / w）的36 将层压体在约38℃发酵干燥46-50小时，然后置于热水提取物用硅藻土过滤，得到提取液和米糠发酵步骤，protease0.05〜米糠发酵提取物（v / W）的0.15％，40 4小时，℃米糠发酵提取物反应而得到的酶降解产物1，并把果胶酶0.05〜0.15％（v / W）的米糠发酵提取物，并使其在45℃反应4小时，米糠发酵提取酶降解产物 - 酶消化步骤，以获得第二和，85℃为失活，并浓缩至灭菌和使用喷雾干燥器中再次混合85℃进行15分钟到15白利糖度和粉状，每次15分钟米糠发酵提取物酶裂解物（入口185±5 ℃，出口95±5℃）以获得米糠发酵酶水解产物-1和米糠发酵水解产物-2 。
-
公开(公告)号：KR1020140052264A
公开(公告)日：2014-05-07
申请号：KR1020120118186
申请日：2012-10-24
Applicant: (주)에스.앤.디
IPC: A61K36/282 , A61K36/258 , A61K36/82 , A61P35/00
Abstract: The present invention relates to a composition to prevent gastritis and cancer containing sugar complex from natural extract and a manufacturing method thereof and, more specifically, to a composition to prevent gastritis and cancer containing herbal extracts selected from Artemisia capillaris, ginseng, and green tea. The manufacturing method for the composition to prevent gastritis and cancer includes an extraction step to put purified water into herbs and extracting herbal extracts; a filtration and concentration step to filter and concentrate the extracted solution; a crystallization step to separate the product into a precipitate and a precipitate filtrate and crystallizing the same; and a dry and pulverization step to dry the crystals separated through the crystallization step and pulverizing the same.
Abstract translation: 本发明涉及一种预防胃炎的组合物和来自天然提取物的含糖复合物的组合物及其制备方法，更具体地，涉及一种预防胃炎的组合物和含有选自艾蒿，人参和绿茶的草药提取物的癌症。 用于预防胃炎和癌症的组合物的制备方法包括将纯化水放入草药中并提取草药提取物的提取步骤; 过滤和浓缩步骤以过滤并浓缩提取的溶液; 将产物分离成沉淀物和沉淀滤液并使其结晶的结晶步骤; 以及干燥和粉碎步骤以干燥通过结晶步骤分离的晶体并粉碎。
-
Patent Agency Ranking
公开(公告)号：KR101241288B1
公开(公告)日：2013-03-14
申请号：KR1020100138117
申请日：2010-12-29
Applicant: (주)에스.앤.디
Abstract: 본 발명은 신규의 고 글루탐산 생성균주 바실러스 서브틸리스(KFCC 11492P) 및 이를 이용한 천연 조미소재의 제조방법에 관한 것이다. 또한, 본 발명은 상기 본 발명의 균주를 이용하여 제조된 천연조미소재에 관한 것이다.
-
公开(公告)号：KR1020130025421A
公开(公告)日：2013-03-11
申请号：KR1020130010580
申请日：2013-01-30
Applicant: (주)에스.앤.디
IPC: A61K31/4045 , A61K31/135 , A61K36/286 , A61K36/906
CPC classification number: A61K31/4045 , A61K31/165 , A61K36/286 , A61K36/906 , A61K2300/00
Abstract: PURPOSE: A complex crude drug extract containing a phenylamide compound is provided to reduce side effects and toxicity, and to treat hyperlipidemia. CONSTITUTION: A complex crude drug extract for treating hyperlipidemia contains a serotonin derivative and a tyramine derivative in a weight ratio of 4:1. The serotonin derivative is N-(p-coumaroyl)serotonin(CS), N-feruloylserotonin(FS), or a mixture thereof. The tyramine derivative is dihydro-N-caffeoyltyramine(DCT), trans-N-caffeoyltyramine(t-CT), or a mixture thereof. [Reference numerals] (AA) Ginger + Safflower seed; (BB) Ginger 1 : Safflower seed B8; (CC) Ginger 1 : Safflower seed B4; (DD) Ginger 1 : Safflower seed B2; (EE) Ginger 1 : Safflower seed B1; (FF) Ginger 2 : Safflower seed B1; (GG) Ginger 4 : Safflower seed B1; (HH) Ginger 8 : Safflower seed B1; (II) Ginger 1 : Safflower seed A1; (JJ) Ginger 2 : Safflower seed A1; (KK) Ginger 4 : Safflower seed A1; (LL) Ginger 8 : Safflower seed A1
Abstract translation: 目的：提供含有苯酰胺化合物的复合生物药物提取物，以减少副作用和毒性，并治疗高脂血症。 构成：用于治疗高脂血症的复杂生药提取物含有重量比为4:1的5-羟色胺衍生物和酪胺衍生物。 5-羟色胺衍生物是N-（对 - 香豆酰基）5-羟色胺（CS），N-亚铁血清素（FS）或其混合物。 酪胺衍生物是二氢-N-咖啡酰基酪氨酸（DCT），反式N-咖啡酰酪胺（t-CT）或其混合物。 （标号）（AA）姜+红花种子; （BB）姜1：红花种子B8; （CC）姜1：红花籽B4; （DD）姜1：红花籽B2; （EE）姜1：红花籽B1; （FF）姜2：红花籽B1; （GG）姜4：红花籽B1; （HH）姜8：红花籽B1; （二）姜1：红花籽A1; （JJ）姜2：红花籽A1; （KK）姜4：红花籽A1; （LL）姜8：红花籽A1
-
公开(公告)号：KR1020120115060A
公开(公告)日：2012-10-17
申请号：KR1020110071839
申请日：2011-07-20
Applicant: (주)에스.앤.디
IPC: A61K36/286 , A61K36/906 , A61P3/06
Abstract: PURPOSE: A complex crude drug extract for treating hyperlipidemia which contains phenyl amide compound is provided to show HMG-CoR inhibition effects and ACAT inhibition effects related to treat and prevent the hyperlipidemia. CONSTITUTION: A complex crude drug extract for treating hyperlipidemia is composed of multiple extract of safflower seed and ginger. The mixing ratio of the safflower seed to ginger is 4:1 in the weight ratio. The Lycii Radicis Cortex extract is additionally added to the extract. The mixing ration of the safflower seed, ginger extract, and the Lycii Radicis Cortex extract is 5:1:1 in the weight ratio. The complex crude drug extract for treating hyperlipidemia is composed of serotonin derivative and tyramine derivative. The mixing ratio of serotonin derivative to the tyramine derivative is 4: 1 in the weight ratio. The serotonin derivative is a mixture of N-(p-coumaroyl) serotonin(CS), N- feruloylserotonin(FS), or a mixture thereof. [Reference numerals] (AA) Ginger+safflower seed; (BB) Ginger 1 : Safflower seed B3; (CC) Ginger 1 : Safflower seed B4; (DD) Ginger 1 : Safflower seed B2; (EE) Ginger 1 : Safflower seed B1; (FF) Ginger 2 : Safflower seed B1; (GG) Ginger 4 : Safflower seed B1; (HH) Ginger 8 : Safflower seed B1; (II) Ginger 1 : Safflower seed A1; (JJ) Ginger 2 : Safflower seed A1; (KK) Ginger 4 : Safflower seed A1; (LL) Ginger 8 : Safflower seed A1
Abstract translation: 目的：提供一种用于治疗含有苯酰胺化合物的高脂血症的复合生药提取物，以显示与治疗和预防高脂血症相关的HMG-CoR抑制作用和ACAT抑制作用。 构成：用于治疗高脂血症的复方生药提取物由红花种子和姜的多次提取物组成。 红花种子与姜的混合比例为4：1。 提取物中还加入Lycii Radicis Cortex提取物。 红花种子，姜提取物和堇菜提取物的混合比例为5：1：1。 用于治疗高脂血症的复方生药提取物由5-羟色胺衍生物和酪胺衍生物组成。 5-羟色胺衍生物与酪胺衍生物的混合比例为重量比为4:1。 5-羟色胺衍生物是N-（对 - 香豆酰基）5-羟色胺（CS），N-阿魏酰基血清素（FS）或其混合物的混合物。 （标号）（AA）姜+红花种子; （BB）姜1：红花籽B3; （CC）姜1：红花籽B4; （DD）姜1：红花籽B2; （EE）姜1：红花籽B1; （FF）姜2：红花籽B1; （GG）姜4：红花籽B1; （HH）姜8：红花籽B1; （二）姜1：红花籽A1; （JJ）姜2：红花籽A1; （KK）姜4：红花籽A1; （LL）姜8：红花籽A1
-
公开(公告)号：KR1020120076107A
公开(公告)日：2012-07-09
申请号：KR1020100138117
申请日：2010-12-29
Applicant: (주)에스.앤.디
Abstract: PURPOSE: A method for producing natural seasoning materials using Bacillus subtilis(KFCC 11492P) producing high glutamic acid is provided to supplement and replace chemical seasoning. CONSTITUTION: A Bacillus subtilis(KFCC 11492P) strain produces glutamic acid of high yield. The glutamic acid is prepared by inoculating the strain in a medium containing natural proteins and culturing. A seasoning material contains amino acids and peptides prepared by inoculating the strain in the medium. The medium contains 1-3 weight parts of defatted soybean meal, 1-5 weight parts of wheat gluten, or mixture thereof.
Abstract translation: 目的：提供使用生产高谷氨酸的枯草芽孢杆菌（KFCC 11492P）生产天然调味料的方法，以补充和替代化学调味料。 构成：枯草芽孢杆菌（KFCC 11492P）菌株产生高产量的谷氨酸。 通过将菌株接种在含天然蛋白质的培养基中并培养来制备谷氨酸。 调味料含有通过将菌株接种在培养基中制备的氨基酸和肽。 该培养基含有1-3重量份脱脂豆粕，1-5重量份小麦面筋或其混合物。
-
公开(公告)号：KR1020110112169A
公开(公告)日：2011-10-12
申请号：KR1020100067918
申请日：2010-07-14
Applicant: (주)에스.앤.디
IPC: A61K36/9066 , A61K31/05 , A61P1/02
CPC classification number: A61K31/05 , A61K36/9066 , A61K2236/30 , A61K2236/51 , A61K2236/55
Abstract: 본 발명은 구강 항균활성을 갖는 잔소리 졸의 제조방법에 관한 것으로, 더욱 상세하게는 커큐마 잔소리자 분말에 유기용매를 혼합하여 항균활성 물질을 추출하는 추출단계, 항균활성 물질이 추출된 유기용매 혼합물을 분리하는 분리단계, 전술한 분리단계를 거쳐 분리된 유기용매 혼합물에 함유된 유기용매를 제거하는 용매제거단계, 유기용매가 제거된 조추출물을 전처리하는 전처리단계, 전처리된 조추출물에 함유된 비극성 물질을 제거하는 비극성물질제거단계, 비극성물질이 제거되어 분획된 추출물을 아세틸레이션하는 아세틸레이션단계, 전술한 아세틸레이션단계를 거친 추출물을 극성차이에 따라 분리하는 항균활성물질분리단계 및 전술한 항균활성물질을 디아세틸레이션하는 디아세틸레이션단계를 포함하여 이루어진다.
-
-
-
-
-
-
-
-
-
Search Results
46
records
(took 0.026 seconds)
